German Cancer Research Center-製薬・医療分野:企業M&A・提携分析

【英語タイトル】German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA8013945)・商品コード:DATA8013945
・発行会社(調査会社):GlobalData
・発行日:2017年11月22日
・ページ数:50
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and prevention, structural and functional genomics, infection and cancer, and tumor immunology. Its services include medical services, technical services, press and public relations, technology transfer, cancer prevention, research works, training among others. DKFZ concentrates on the transfer of approaches in the prevention, diagnosis and treatment of cancer to clinical application. The institute operates through its facilities including centre for preclinical research, genomics and proteomics, imaging and cytometry, information technology, library, animal laboratory services and chemical biology. DKFZ is headquartered in Heidelberg, Germany.

German Cancer Research Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
German Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
German Cancer Research Center, Medical Devices Deals, 2011 to YTD 2017 10
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
German Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Apogenix Secures US$9.8 Million In Venture Financing 13
Partnerships 14
Leica Microsystems Enters Into Licensing Agreement With Max Planck Society And German Cancer Research 14
ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 15
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center For Cancer Therapies 16
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center 17
Genetic Immunity Enters Into Agreement With German Cancer Research Center To Develop HPV Therapeutic Vaccine 18
German Cancer Research Center And University Medical Center Enter Into An Agreement With International Cancer Genome Consortium 19
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center 21
Licensing Agreements 22
Imaxio Enters into License Agreement with German Cancer Research 22
Sciomics Enters into Licensing Agreement with German Cancer Research Center 23
German Cancer Research Center – Key Competitors 24
German Cancer Research Center – Key Employees 25
German Cancer Research Center – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 26
Recent Developments 27
Government and Public Interest 27
Aug 23, 2017: Chaos in cell division – How chromosomal defects arise in cancer cells 27
Aug 02, 2017: Therapies for Older Leukemia Patients 28
Jun 30, 2017: €5.7 Million for Novel Treatment Approaches in Pediatric Brain Cancer 29
Jun 28, 2017: Improving Outcomes Through Personalized Medicine 30
Jun 12, 2017: Mysterious gene transcripts after cancer therapy 31
May 29, 2017: Macrophages control the development of nerves and blood vessels in the brain 32
May 02, 2017: Tailor-made viruses for enhanced cancer therapy 33
Apr 10, 2017: Human blood cells develop in a continuous process instead of a stepwise one 34
Apr 07, 2017: European million grants for three DKFZ researchers 35
Jan 03, 2017: DKFZ-researcher receives ERC-Grant 36
Nov 17, 2016: Research to Combat Pancreatic Cancer 37
Sep 07, 2016: Medication against schizophrenia inhibits pancreatic cancer 39
Aug 08, 2016: One million € funding for the development of norovirus therapeutics 40
Feb 26, 2016: New brain cancer types emerge based on molecular characteristics 41
Feb 25, 2016: Pancreatic Cancer: Enzyme renders tumors resistant 42
Feb 15, 2016: Oncogene controls stem cells in early embryonic development 43
Feb 02, 2016: DKTK: Incentive for clinically relevant cancer research: Joint Funding Contest rewards outstanding methods of diagnosis and therapy 44
Jan 28, 2016: Mining the epigenome to identify likely origins of childhood brain tumor subtype 46
Jan 28, 2016: Award-winning finding in the cancer genome 48
Jan 14, 2016: Breast cancer research award for Karen Steindorf 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
German Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
German Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
German Cancer Research Center, Deals By Therapy Area, 2011 to YTD 2017 9
German Cancer Research Center, Medical Devices Deals, 2011 to YTD 2017 10
German Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Apogenix Secures US$9.8 Million In Venture Financing 13
Leica Microsystems Enters Into Licensing Agreement With Max Planck Society And German Cancer Research 14
ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 15
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center For Cancer Therapies 16
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center 17
Genetic Immunity Enters Into Agreement With German Cancer Research Center To Develop HPV Therapeutic Vaccine 18
German Cancer Research Center And University Medical Center Enter Into An Agreement With International Cancer Genome Consortium 19
Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center 21
Imaxio Enters into License Agreement with German Cancer Research 22
Sciomics Enters into Licensing Agreement with German Cancer Research Center 23
German Cancer Research Center, Key Competitors 24
German Cancer Research Center, Key Employees 25
German Cancer Research Center, Subsidiaries 26
German Cancer Research Center, Joint Venture 26

★調査レポート[German Cancer Research Center-製薬・医療分野:企業M&A・提携分析] (コード:DATA8013945)販売に関する免責事項を必ずご確認ください。
★調査レポート[German Cancer Research Center-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆